Durable responses have continued to be seen two years after administration of Sarepta’s candidate gene therapy to four boys with...
The appointment of Belén Garijo as CEO of the German major from May next year is a small but significant...
A letter from more than 60 leading public health and medical ethics experts has been sent to Pfizer's CEO Albert...
With digital marketing initiatives becoming key to communication with health providers, COVID-19 has presented the perfect storm to place customers...
From AI-assisted drug discovery to oncotherapy development, China has seen investment pour in over the past week, while the nation's...
Novartis thwarts Sun’s efforts to commercialize nilotinib in India, though the Indian firm indicates that its actions are covered under...
Public Company Edition: Outside the US, Zai Lab raised more in its recent Hong Kong initial public offering – $766.4m...
The firm licensed the TLR9 agonist SD-101 from Dynavax to test with its pressure-enabled drug delivery technology in liver and...
The US FDA appears to have concerns about the device used to administer the vaccine.
Galapagos and Gilead's JAK inhibitor has been approved for rheumatoid arthritis in the second and third biggest pharma markets, softening...